{"id":55040,"date":"2023-08-30T19:05:14","date_gmt":"2023-08-30T23:05:14","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/outlook-therapeutics-stock-tumbles-71-premarket-after-fda-rejects-treatment-for-wet-amd\/"},"modified":"2023-08-30T19:05:18","modified_gmt":"2023-08-30T23:05:18","slug":"outlook-therapeutics-stock-tumbles-71-premarket-after-fda-rejects-treatment-for-wet-amd","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=55040","title":{"rendered":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD"},"content":{"rendered":"
\n

Outlook Therapeutics Inc.\u2019s stock
\n OTLK,
\n -80.96%<\/bg-quote>
\n tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has issued a Control Response Letter for the company\u2019s Biologics License Application for a treatment for wet age-related macular degeneration. The FDA issues a CRL when it\u2019s unable to approve a drug in its current form, and is seeking further confirmatory clinical evidence. The treatment called ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to treat wet AMD, Iselin, N.J.-based Outlook said in a statement. The company is working to address the regulator\u2019s issues. \u201cWhile the FDA acknowledged the NORSE TWO pivotal trial met its safety and efficacy endpoints, the agency concluded it could not approve the BLA during this review cycle due to several CMC issues, open observations from pre-approval manufacturing inspections, and a lack of substantial evidence,\u201d said the statement. The stock is up 30% in the year to date, while the S&P 500 has gained 17%. <\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has issued a Control Response Letter for the company\u2019s Biologics License Application for a treatment for wet age-related macular degeneration. The FDA issues a CRL when it\u2019s unable to approve a drug in […]<\/p>\n","protected":false},"author":1,"featured_media":1383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-55040","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"\nOutlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld<\/title>\n<meta name=\"description\" content=\"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=55040\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=55040\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T23:05:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-30T23:05:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t<meta property=\"og:image:height\" content=\"742\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=55040#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=55040\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD\",\"datePublished\":\"2023-08-30T23:05:14+00:00\",\"dateModified\":\"2023-08-30T23:05:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=55040\"},\"wordCount\":185,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=55040#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=55040\",\"url\":\"https:\/\/ifintechworld.com\/?p=55040\",\"name\":\"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-08-30T23:05:14+00:00\",\"dateModified\":\"2023-08-30T23:05:18+00:00\",\"description\":\"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=55040#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=55040\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=55040#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld","description":"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=55040","og_locale":"en_US","og_type":"article","og_title":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld","og_description":"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has","og_url":"https:\/\/ifintechworld.com\/?p=55040","og_site_name":"iFintechWorld","article_published_time":"2023-08-30T23:05:14+00:00","article_modified_time":"2023-08-30T23:05:18+00:00","og_image":[{"width":1320,"height":742,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=55040#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=55040"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD","datePublished":"2023-08-30T23:05:14+00:00","dateModified":"2023-08-30T23:05:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=55040"},"wordCount":185,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=55040#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=55040","url":"https:\/\/ifintechworld.com\/?p=55040","name":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-08-30T23:05:14+00:00","dateModified":"2023-08-30T23:05:18+00:00","description":"Outlook Therapeutics Inc.\u2019s stock OTLK, -80.96% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration has","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=55040#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=55040"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=55040#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Outlook Therapeutics\u2019 stock tumbles 71% premarket after FDA rejects treatment for wet AMD"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/55040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55040"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/55040\/revisions"}],"predecessor-version":[{"id":55041,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/55040\/revisions\/55041"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1383"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}